TATVA — Tatva Chintan Pharma Chem Income Statement

0.000.00%

Last trade - 00:00

Basic MaterialsAdventurousSmall CapHigh Flyer

Annual income statement for Tatva Chintan Pharma Chem, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	C2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	3,004	4,336	4,236	3,935	3,827
Cost of Revenue
Gross Profit	1,321	2,034	1,654	1,753	1,838
Selling / General / Administrative Expenses
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	2,406	3,335	3,653	3,498	3,762
Operating Profit	598	1,002	583	437	65.5
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	607	1,041	448	436	75.8
Provision for Income Taxes
Net Income After Taxes	523	959	455	304	57.1
Net Income Before Extraordinary Items
Net Income	523	959	455	304	57.1
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	523	959	455	304	64.2
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	23.6	44.6	21.6	13.3	2.44
Dividends per Share